Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact [email protected].
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
| Browse by: | Sort by: |
One Size Doesn't Fit All: How Direct and Indirect Mineralocorticoid Actions Control Distal Nephron Sodium Transport
David Ellison, MD
Oregon Health and Science University, Portland, OR
Available
Glucocorticoid Metabolism in Salt-Induced Hypertension
Matthew Bailey, PhD, FRSB
The University of Edinburgh, Edinburgh, United Kingdom
Available
Mechanisms of Fructose-Mediated Hypertension: Sodium, RAS and Sympathetic Regulation
Noreen Rossi, MD
Wayne State University, Detroit, MI
Available
ANGPTL Proteins and the Pathogenesis of Metabolic Disease
Brandon Davies, PhD
University of Iowa, Iowa City, IA
Available
Molecular Interplay Between LPL, GPIHBP1 and ANGPTLs - When Protein Disorder Regulates Intravascular Lipolysis
Michael Ploug, PhD, DSc
Finsen Laboratory & Biotech Research & Innovation Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Available
The Role of ANGPTL4 in Macrophages and Adipocytes
Sander Kersten, PhD
Wageningen University, Wageningen, Netherlands
Available
Chair
Maria-Christina Zennaro, MD, PhD
Inserm, Paris, France
Chair
Adina Turcu, MD
University of Michigan Medical School, Ann Arbor, MI
Welcome and Introductions
Aldosterone and Cardiometabolic Disease in African Americans
Joshua Joseph, MD
Ohio State University College of Medicine, Columbus, OH
Live Moderated Q&A
Genetic Advances in Familial and Sporadic Primary Aldosteronism and Their Potential Clinical Implications
Isabelle Bourdeau, MD
Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada
Live Moderated Q&A
New Mechanisms in the Pathophysiology of Primary Aldosteronism
Tracy Williams, PhD
University of Turin, Torino, Italy
Live Moderated Q&A and Session Closing
Available
Meet the Professor
Emily Jefferson, PhD
University of Dundee, Nethergate, United Kingdom
Available
Chair
Jeremy Tomlinson, BA,BM,BCH,MRCP,MD
University of Oxford, Woodstock, United Kingdom
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
Emilie Gobeil, BSc
Laval University, Quebec City, QC, Canada
Audience Q&A
Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
Konstantinos Stefanakis, MD Student
Beth Israel Deaconess Medical Center, Harvard Medical School; Boston VA Healthcare System, Boston, MA
Audience Q&A
Leptin Improves Cardiac Structure and Function in Patients With Generalized Lipodystrophy
Rebecca Brown, MD
National Institutes of Health, Bethesda, MD
Audience Q&A
The Impact of ACTH on Peripheral Steroids Differs between Unilateral and Bilateral Primary Aldosteronism
Yuta Tezuka, MD, PhD
UNIVERSITY OF MICHIGAN, Ann arbor, MI
Audience Q&A
Available
Moderator
Andrew Bauer, MD
The Children's Hospital of Philadelphia, Haddonfield, NJ
Faculty
Don Wilson, MD
Cook Children's Endocrinology, North Richland Hills, TX
Case Presentation
Live Moderated Q&A
Case Presentation
Live Moderated Q&A and Session Closing
Available
Moderator
Massimiliano Caprio, MD,PhD
San Raffaele Roma Open University, Rome, Italy
Faculty
Ronald Krauss, MD
University of California, San Francisco, San Francisco, CA
Case Presentation
Live Moderated Q&A and Session Closing
Available
Chair
Ayotunde Dokun, MD, PhD
University of Iowa, Iowa City, IA
Welcome and Introductions
Fuel Metabolism and Mitochondria: New Strategies for the Failing Heart
Daniel Kelly, MD
Pennsylvania Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA
Live Moderated Q&A
GPCR Signaling Cross-Talk Between Heart and Adipose Tissues Identifies New Targets for Cardio-Metabolic Disease
Walter Koch, PhD
Temple University School of Medicine, Philadelphia, PA
Live Moderated Q&A
Cardiac Function in Type 2 Diabetes and Exercise Intolerance: Where Does Sex Fit In?
Jane Reusch, MD
Denver Veterans Affairs Medical Center, Aurora, CO
Live Moderated Q&A and Session Closing
Available
Moderator
Patrick McBride, MD, MPH
University of Wisconsin Madison, Madison, WI
Panelist
Connie Newman, MD
New York University School of Medicine, Warren, NJ
Panelist
Lisa Tannock, MD
University of Kentucky, Lexington, KY
Panelist
Ira Goldberg, MD
New York University Medical Center, New York, NY
Panelist
Alan Chait, MBChB, MD
University of Washington, Seattle, WA
Discussion Q&A
Available
Chair
Kim Jonas, PhD, BSc, PGCert
King's College London, London, United Kingdom
FGF-2-Dependent Signaling Activated in Aged Human Skeletal Muscle Promotes Intramuscular Adipogenesis
Sebastian Mathes, MSc
University Hospital Zurich, Zurich, Switzerland
Audience Q&A
Human GPR17 Nonsynonymous Variants Identified in Individuals with Metabolic Diseases Have Distinct Functional Signaling Profiles
Jason Conley, PhD
Indiana University School of Medicine, Indianapolis, IN
Audience Q&A
Dapagliflozin Exerts Adrenal Sympatholysis via G protein-Coupled Receptor Kinase-2 & Tyrosine Hydroxylase Downregulation
Anastasios Lymperopoulos, PhD
Nova Southeastern University, Davie, FL
Audience Q&A
An Epigenomic Signature in Children Born Small for Gestational Age (SGA) With “Catch-up” Growth Is Present From Birth and Predicts Early Adulthood Pre-Hypertension
Terence Garner, MSc
University of Manchester, Manchester, United Kingdom
Audience Q&A
Available
Familial Lipid Disorders: What Every Lipid-Savvy Endocrinologist Needs to Know
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
Kenneth Feingold, MD
University of California, San Francisco, San Francisco, CA
Paid users only
Slides + audio
Available
Is HDL a Risk Factor or Risk Marker? The Clinical Take-Home Message
Jay Heinecke, MD
University of Washington Medical Center, Seattle, WA
Permission not
granted for presentation
granted for presentation
New Cholesterol Guidelines 2018
Neil J Stone, MD
Northwestern University, Chicago, IL
Paid users only
Slides + audio
Available
Cholesterol-Carrying Lipoproteins and CVD Risk
Anne Carol Goldberg, MD
Washington Univ School of Med, Saint Louis, MO
Permission not
granted for presentation
granted for presentation
Residual Risk: How to Assess Risk beyond the ASCVD Risk Calculator
Marc-Andre Cornier, MD
University of Colorado School of Medicine, Aurora, CO
Paid users only
Slides + audio
Available
Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and Beyond
Carol H Wysham, MD
MultiCare Rockwood Clinic, Spokane, WA
Daniel J Drucker, MD
Mt Sinai Hospital, Toronto, ON
Jane E Reusch, MD
Rocky Mountain Regional VAMC, Aurora, CO
Hertzel C Gerstein, MD, MSc
McMaster University, Hamilton, ON
Paid users only
Slides + audio
Coming soon
Pharmacotherapy for Lipid Disorders: Which Drugs for Which Disease
Robert Eckel, MD
University of Colorado Anschutz Medical Campus, Aurora, CO
Paid users only
Slides + audio
Available
Outstanding Educator Award Presented to Kenneth Burman, MD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Paid users only
Slides + audio
Available
Sidney H. Ingbar Award Presented to Carole Mendelson, PhD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Paid users only
Slides + audio
Available
Senescent cells: An Emerging Targetfor Diseases of Aging
Jan M van Deursen, PhD
Mayo Clinic, Rochester, MN
Paid users only
Slides + audio
Coming soon
Targeting Cellular Senescence in Age-Related Osteoporosis and Frailty
Sundeep Khosla, MD
Mayo Clinic, Rochester, MN
Paid users only
Slides + audio
Available
